NCT01840306View on ClinicalTrials.gov

Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

October 12, 2012

Primary Completion Date

May 24, 2023

Study Completion Date

May 24, 2023

Conditions
Breast CancerHER2 Positive Breast CancerHER2 Negative Breast Cancer
Interventions
OTHER

Biomarker Analysis

Trial Locations (11)

Unknown

Bon Secours Hospital, Cork

Cork University Hospital, Cork

Letterkenny General Hospital, Donegal

Our Lady of Lourdes Hospital, Drogheda

Beacon Hospital, Dublin

Beaumont Hospital, Dublin

St James's Hospital, Dublin

St Vincent's University Hospital, Dublin

The Adelaide & Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin

Sligo General Hospital, Sligo

University Hospital Waterford, Waterford

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT01840306 - Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer | Biotech Hunter | Biotech Hunter